Find a Clinical Trial
The clinical trials at Gundersen offer the same cutting-edge treatments as those at other top medical research hospitals – and often much sooner than they’re available to everyone.
Showing 9 of 89 trials
NCI-2014-01509
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Adult (18-64)
Older adult (65+)
NCI-2020-06838
Testing the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA Mutations
Adult (18-64)
Older adult (65+)
NCI-2014-02674
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
Adult (18-64)
Older adult (65+)
NCI-2021-09851
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
Adult (18-64)
Older adult (65+)
TP-CA-002
GEMINI-NSCLC: NSCLC Biomarker Study
Adult (18-64)
Older adult (65+)
NCI-2017-01017
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Adult (18-64)
Older adult (65+)
CLN01001
Endovascular Engineering ENGULF Study
Adult (18-64)
Older adult (65+)
NCI-2024-01987
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Adult (18-64)
Older adult (65+)
NCI-2022-06842
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Child (birth - 17)
Adult (18-64)
Older adult (65+)